Hyaluronic Acid‐Guided Cerasome Nano‐Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis
Authors:
Open Access
- 18 December 2022
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (5)
Abstract
Early noninvasive screening and regression therapy for vulnerable atherosclerotic plaques remain challenging. In this study, it is aimed to develop a new approach for the active targeting of atherosclerotic plaques with nano‐agents to aid imaging and treatment. Biocompatible hyaluronic acid (HA)‐guided cerasomes are generated to selectively target CD44‐positive cells within the plaque in in vitro studies and in vivo testing in Apoe−/− mice. Rosuvastatin (RST) is encapsulated in the HA‐guided cerasome nano‐formulation to produce HA‐CC‐RST, which results in significant plaque regression as compared to treatment with the free drug. Moreover, gadodiamide‐loaded HA‐CC enhances magnetic resonance images of vulnerable plaques, thereby attaining the goal of improved simultaneous treatment and imaging. Transcriptomic analysis confirms plaque regression with HA‐CC–RST treatment, which potentially benefits from the anti‐inflammatory effect of RST. In summary, a safe and efficient nano‐formulation for the targeted delivery of active agents to atherosclerotic plaques is developed and may be applicable to other diagnostic and therapeutic agents for atherosclerosis treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81400324)
- Natural Science Foundation of Beijing Municipality (7182048)
This publication has 30 references indexed in Scilit:
- Nanotechnology in Diagnosis and Treatment of Coronary Artery DiseaseNanomedicine, 2016
- Safety evaluation of liposomal nanohybrid cerasomes and their application in the release of 10-hydroxycamptothecinRSC Advances, 2016
- Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic ApplicationsCardiovascular Drugs and Therapy, 2016
- Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerFrontiers in Immunology, 2015
- Stabilized liposomal nanohybrid cerasomes for drug delivery applicationsChemical Communications, 2010
- CD44 Expressed on Both Bone Marrow–Derived and Non–Bone Marrow–Derived Cells Promotes Atherogenesis in ApoE-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid PlaqueCirculation, 2005
- Stable vesicular nanoparticle ‘Cerasome’ as an organic–inorganic hybrid formed with organoalkoxysilane lipids having a hydrogen-bonding unitThin Solid Films, 2003
- The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationJournal of Clinical Investigation, 2001
- The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationJournal of Clinical Investigation, 2001